Proteomic analysis of serum proteins in acute ischemic stroke patients treated with acupuncture

Experimental Biology and Medicine

Volumn 236, Issue 3, 2011, Pages 325-333

  Pan, Sanqiang ^a   Zhan, Xiangli ^a   Su, Xuan ^b   Guo, Lei ^a   Lv, Laiqing ^a   Su, Baogui ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b Nanhai Chinese Traditional Hospital   (China)

Author keywords

Electroacupuncture; Muscle strength; Serum; Stroke; Two dimensional electrophoresis

Indexed keywords

BETA2 GLYCOPROTEIN 1; COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4B; ERIGERON BREVISCAPUS EXTRACT; GELSOLIN; SERPING1 PROTEIN; UNCLASSIFIED DRUG;

AGED; ARM MUSCLE; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPARATIVE STUDY; CONTROLLED STUDY; ELECTROACUPUNCTURE; FEMALE; HUMAN; INTERMETHOD COMPARISON; LEG MUSCLE; MALE; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING;

ACUPUNCTURE; BLOOD PROTEINS; BLOTTING, WESTERN; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MUSCLE STRENGTH; PROTEOMICS; STROKE; TREATMENT OUTCOME;

EID: 79953184705     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.010041     Document Type: Article

References (41)

1. World Health Organization. The World Health Report 2003: Shaping the Future. Geneva: World Health Organization, 2003. See http://www.who.int/whr/ 2003/en/whr03-en.pdf (last checked 25 February 2011)
2. Kim YS, Hong JW, Na BJ, Park SU, Jung WS, Moon SK, Park JM, Ko CN, Cho KH, Bae HS. The effect of low versus high frequency electrical acupoint stimulation on motor recovery after ischemic stroke by motor evoked potentials study. Am J Chin Med 2008;36:45-54 (Pubitemid 351711742)
3. Wong AMK, Su TY, Tang FT, Cheng PT, Liaw MY. Clinical trial of electrical acupuncture on hemiplegic stroke patients. Am J Phys Med Rehabil 1999;78:117-22 (Pubitemid 29135755)
4. Gosman-Hedstrom G, Claesson L, Klingenstierna U, Carlsson J, Olausson B, Frizell M, Fagerberg B, Blomstrand C. Effects of acupuncture treatment on daily life activities and quality of life: a controlled, prospective, and randomized study of acute stroke patients. Stroke 1998;29:2100-8 (Pubitemid 28443525)
5. Hopwood V, Lewith G, Prescott P, Campbell MJ. Evaluating the efficacy of acupuncture in defined aspects of stroke recovery: a randomised, placebo controlled single blind study. J Neurol 2008;255:858-66
6. Montaner J, Perea-Gainza M, Delgado P, Ribó M, Chacón P, Rosell A, Quintana M, Palacios ME, Molina CA, Alvarez-Sabín J. Etiologic diagnosis of ischemic stroke subtypes with plasma biomarkers. Stroke 2008;39:2280-7
7. Mayer SA, Linares G. Can a simple blood test quantify brain injury? Crit Care 2009;13:166
8. Laskowitz DT, Kasner SE, Saver J, Remmel KS, Jauch EC, BRAIN Study Group. Clinical usefulness of a biomarker-based diagnostic test for acute stroke: the biomarker rapid assessment in ischemic injury (BRAIN) study. Stroke 2009;40:77-85
9. Laskowitz DT, Blessing R, Floyd J, White WD, Lynch JR. Panel of biomarkers predicts stroke. Ann N Y Acad Sci 2005;1053:30 (Pubitemid 43031078)
10. Medical Research Council. Aids to examination of the peripheral nervous system. Memorandum no. 45. London: Her Majesty's Stationary Office, 1976
11. Florence JM, Pandya S, King WM, Robison JD, Signore LC, Wentzell M, Province MA. Clinical trials in Duchenne dystrophy: standardization and reliability of evaluation procedures. Phys Ther 1984;64:41-5 (Pubitemid 14219737)
12. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993;24:35-41
13. Jing-xian H. Apoplexy treated with xingnao kaiqiao acupuncture therapy principle. Chin J Integrat Med 2003;9:5-6
14. Chu Q, Wu T, Fu L, Ye J. Simultaneous determination of active ingredients in Erigeron breviscapus (Vant.) Hand-Mazz. by capillary electrophoresis with electrochemical detection. J Pharm Biomed Anal 2005;37:535-41 (Pubitemid 40312299)
15. Lin LL, Liu AJ, Liu JG, Yu XH, Qin LP, Su DF. Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats. J Cardiovasc Pharmacol 2007;50:327-32
16. Wang ZY, Chen DC, He Y, Ruan CG, Zhang RW. Differential effects of new breviscapine on arachidonic acid metabolisms in blood cells and endothelial cells. Zhongguo Yao Li Xue Bao 1993;14:148-51 (Pubitemid 23113974)
17. Hu XM, Zhou MM, Hu XM, Zeng FD. Neuroprotective effects of scutellarin on rat neuronal damage induced by cerebral ischemia/reperfusion. Acta Pharmacol Sin 2005;26:1454-9
18. Davis AE 3rd, Mejia P, Lu F. Biological activities of C1 inhibitor. Mol Immunol 2008;45:4057-63
19. Buerke M, Murohara T, Lefer AM. Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion. Circulation 1995;91:393-402
20. Fu J, Lin G, Wu Z, Ceng B, Wu Y, Liang G, Qin G, Li J, Chiu I, Liu D. Anti-apoptotic role for C1 inhibitor in ischemia/reperfusion-induced myocardial cell injury. Biochem Biophys Res Commun 2006a;349:504-12 (Pubitemid 44344551)
21. Akita N, Nakase H, Kaido T, Kanemoto Y, Sakaki T. Protective effect of C1 esterase inhibitor on reperfusion injury in the rat middle cerebral artery occlusion model. Neurosurgery 2003;52:395-400
22. De Simoni MG, Rossi E, Storini C, Pizzimenti S, Echart C, Bergamaschini L. The powerful neuroprotective action of C1-inhibitor on brain ischemia reperfusion injury does not require C1q. Am J Pathol 2004; 164:1857-63 (Pubitemid 38529788)
23. Trouw LA, Blom AM, Gasque P. Role of complement and complement regulators in the removal of apoptotic cells. Mol Immunol 2008;45:1199-207 (Pubitemid 350299480)
24. Rahpeymai Y, Hietala MA, Wilhelmsson U, Fotheringham A, Davies I, Nilsson AK, Zwirner J, Wetsel RA, Gerard C, Pekny M, Pekna M. Complement: a novel factor in basal and ischemia-induced neurogenesis. EMBO J 2006;25:1364-74
25. Pawelec G, Barnett Y, Forsey R, Frasca D, Globerson D, McLeod J, Caruso C, Franceschi C, Fulop T, Gupta S, Mariani E, Mocchegiani E, Solana R. T cells and aging. Front Biosci 2002;7:1056-183
26. Al-Rayes H, Pachas W, Mirza N, Ahern DJ, Geha RS, Vercelli D. IgE regulation and lymphokine patterns in aging humans. J Allerg Clin Immunol 1992;90:630-6
27. Balasubramanian K, Schroit AJ. Characterization of phosphatidylserine- dependent beta2-glycoprotein I macrophage interactions. Implications for apoptotic cell clearance by phagocytes. J Biol Chem 1998;273:29272-77 (Pubitemid 28507629)
28. Brighton TA, Hogg PJ, Dai YP, Murray BH, Chong BH, Chesterman CN. Beta2-glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant. Br J Haematol 1996;93:185-94 (Pubitemid 26132396)
29. Galli M, Ruggeri L, Barbui T. Differential effects of anti-beta2-glycoprotein I and antiprothrombin antibodies on the anticoagulant activity of activated protein C. Blood 1998;91:1999-2004 (Pubitemid 28185500)
30. Rouayrenc JF, Fattoum A, Gabrion J, Audemard E, Kassab R. Muscle gelsolin: isolation from heart tissue and characterization as an integral myofibrillar protein. FEBS Lett 1984;167:52-8 (Pubitemid 14198832)
31. Sun HQ, Yamamoto M, Mejillano M, Yin HL. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem 1999;274:33179-82 (Pubitemid 129511609)
32. Dabrowska R, Hinssen H, Gałazkiewicz B, Nowak E. Modulation of gelsolin-induced actin-filament severing by caldesmon and tropomyosin and the effect of these proteins on the actin activation of myosin Mg(2+)-ATPase activity. Biochem J 1996;315:753-9
33. Page LJ, Suk JY, Bazhenova L, Fleming SM, Wood M, Jiang Y, Guo LT, Mizisin AP, Kisilevsky R, Shelton GD, Balch WE, Kelly JW. Secretion of amyloidogenic gelsolin progressively compromises protein homeostasis leading to the intracellular aggregation of proteins. Proc Natl Acad Sci USA 2009;106:11125-30
34. Unger A, Hinssen H. Electron-microscopical localization of gelsolin in various crustacean muscles. Cell Tissue Res 2010;341:313-23
35. Witke W, Li W, Kwiatkowski DJ, Southwick FS. Comparisons of CapG and gelsolin-null macrophages:demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing. J Cell Biol 2001;154:775-84 (Pubitemid 34292959)
36. Arora PD, Glogauer M, Kapus A, Kwiatkowski DJ, McCulloch CA. Gelsolin mediates collagen phagocytosis through a rac-dependent step. Mol Biol Cel 2004;15:588-99 (Pubitemid 38146476)
37. Ohtsu M, Sakai N, Fujita H, Kashiwagi M, Gasa S, Shimizu S, Eguchi Y, Tsujimoto Y, Sakiyama Y, Kobayashi K, Kuzumaki N. Inhibition of apoptosis by the actin regulatory protein gelsolin. EMBO J 1997;16:4650-6 (Pubitemid 27326602)
38. Azuma T, Koths K, Flanagan L, Kwiatkowski D. Gelsolin in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic progression. J Bio Chem 2000;275:3761-6 (Pubitemid 30094596)
39. Endres M, Fink K, Zhu J, Stagliano NE, Bondada V, Geddes JW, Azuma T, Mattson MP, Kwiatkowski DJ, Moskowitz MA. Neuroprotective effects of gelsolin during murine stroke. J Clin Invest 1999;103: 347-54 (Pubitemid 29069984)
40. Ahn JS, Jang IS, Kim DI, Cho KA, Park YH, Kim K, Kwak CS, Chul Park S. Aging-associated increase of gelsolin for apoptosis resistance. Biochem Biophys Res Commun 2003;312:1335-41 (Pubitemid 37490963)
41. Ahn JS, Jang IS, Rhim JH, Kim K, Yeo EJ, Park SC. Gelsolin for senescence-associated resistance to apoptosis. Ann N Y Acad Sci 2003;1010:493-5 (Pubitemid 38265032)